OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
The integrity of filter membranes is critical for maintaining sterile filtration.
Will traditional testing methods work for new therapeutic modalities?
Common analysis approaches may be robust but still have limitations.
Development timelines must accommodate all crucial elements of toxicology studies.
February 04, 2021
PathoQuest will apply its experience in viral safety testing and quality control of biologics for mitigating the risk of adventitious agent contamination in biopharmaceutical manufacturing.
February 03, 2021
This article provides an overview of the key risks that can be associated with the use of secondary reference standards (RS) and illustrates scientific challenges associated with transitioning from pharmacopeial RS to secondary RS.
Sharing process insights across the stages of drug development improves tech transfer.
February 02, 2021
Common approaches to analyze elemental impurities for compliance with regulatory requirements are robust but still have some limitations.
Having a clear and detailed understanding of exactly what a biomolecule entails is essential for therapeutics development.
February 01, 2021
Nexelis’ recent acquisition of GSK’s Marburg, Germany-based vaccines clinical bioanalytical laboratory expands its bioanalytical capabilities.
The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.
January 04, 2021
Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%.
January 03, 2021
Biopharma looks to deliver on COVID-19 vaccines and other promising therapies.
Essential bio/pharma employees show hard work and dedication can pay off for patients.
Demand for specific advanced laboratory skills drives creates a positive employment market.
January 02, 2021
Traditional biologic-based testing methods may need an upgrade to properly test newer therapeutic modalities.
December 03, 2020
A novel PTA technology captures more than 95% of the genomes of single cells, providing more uniform, accurate, and reproducible single-cell analysis data.
December 02, 2020
Pharmaceutical laboratories must keep lab data integrity practices in mind in order to properly handle the effects of the COVID-19 pandemic.
December 01, 2020
The expansion of the companies’ partnership will integrate lead optimization efforts to advance cancer immune therapy drug discovery.
Dolomite Microfluidics and MilliporeSigma have begun a collaboration to release off-the-shelf microfluidic device kits for the fabrication of PLGA particles.
The new powerful, precise, and compact instrument can be retrofitted for point-of-care clinical testing at urgent care facilities, hospitals, or physicians’ offices.
November 23, 2020
The partners have established PathoQuest, Inc., a US subsidiary, and will construct an NGS-based testing lab at Charles River’s Wayne, PA, site.
November 05, 2020
Samsung Biologics has adopted Solentim’s cell seeding and cell metric platforms at its new R&D center in San Francisco, CA.
November 04, 2020
Mogrify’s new technology platform, EpiMOGRIFY, can predict cellular switches important for determining cell identity, cell maintenance, directed differentiation, and cell conversion.